If we assume all patients who began treatment with Casgevy last year progress to the administration stage, CRISPR and Vertex ...

Crispr Therapeutics AG (CRSP) stock saw a decline, ending the day at $38.85 which represents a decrease of $-0.84 or -2.12% from the prior close of $39.69. The stock opened at $39.06 and touched a low ...

Technology Networks spoke with Dr. Thomas Dennison, University of Cambridge, to learn more about the advantages of using ...

Morgan Stanley analyst Terence Flynn maintained a Hold rating on Vertex Pharmaceuticals (VRTX – Research Report) today and set a price target ...

Check the time stamp on this data. Updated AI-Generated Signals for Crispr Therapeutics Ag (CRSP) available here: CRSP. Type ...

In a report released today, Alec Stranahan from Bank of America Securities maintained a Buy rating on Intellia Therapeutics (NTLA – Research ...

An investigational induced pluripotent stem cell-derived CAR natural killer cell therapy was well tolerated both as ...

Unsurprisingly, Hawaii and Alaska spend the most on groceries. '1,000-Lb. Sisters' star Tammy Slaton has lost 500 pounds.

New York Governor Kathy Hochul delivered her 2025 State of the State address on Tuesday, focusing on affordability and public ...

Several large drugmakers will ask the Trump administration to pause Medicare drug-price negotiations, even as Biden-appointed ...

Cathie Wood's ARK Investment Management adds to its stake in Tempus AI ( NASDAQ:TEM) after the stock tumbled nearly 14% on Monday, January 13 4:00 PM ET. The company announces preliminary ...